Rankings
▼
Calendar
FLGT Q4 2024 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena
FLGT
Fulgent Genetics, Inc.
$458M
Q4 2024 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$76M
+8.1% YoY
Gross Profit
$32M
41.8% margin
Operating Income
-$16M
-21.2% margin
Net Income
-$6M
-7.7% margin
EPS (Diluted)
$-0.19
QoQ Revenue Growth
+6.2%
Cash Flow
Operating Cash Flow
$25M
Free Cash Flow
$21M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$91M
Stockholders' Equity
$1.1B
Cash & Equivalents
$55M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$76M
$71M
+8.1%
Gross Profit
$32M
$25M
+26.2%
Operating Income
-$16M
-$151M
+89.3%
Net Income
-$6M
-$128M
+95.4%
Revenue Segments
Laboratory Services
$141M
100%
Geographic Segments
UNITED STATES
$129M
85%
Non-US
$11M
8%
CHINA
$7M
5%
Other Countries
$4M
3%
← FY 2024
All Quarters
Q1 2025 →